B. Van Calster
Katholieke Universiteit Leuven
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by B. Van Calster.
Ultrasound in Obstetrics & Gynecology | 2008
D. Timmerman; Antonia Carla Testa; Tom Bourne; L. Ameye; D. Jurkovic; C. Van Holsbeke; D. Paladini; B. Van Calster; Ignace Vergote; S. Van Huffel; Lil Valentin
To derive simple and clinically useful ultrasound‐based rules for discriminating between benign and malignant adnexal masses.
Ultrasound in Obstetrics & Gynecology | 2010
D. Timmerman; B. Van Calster; Antonia Carla Testa; S. Guerriero; D. Fischerova; Andrea Lissoni; C. Van Holsbeke; R. Fruscio; A. Czekierdowski; D. Jurkovic; L. Savelli; Ignace Vergote; Tom Bourne; S. Van Huffel; Lil Valentin
The aims of the study were to temporally and externally validate the diagnostic performance of two logistic regression models containing clinical and ultrasound variables in order to estimate the risk of malignancy in adnexal masses, and to compare the results with the subjective interpretation of ultrasound findings carried out by an experienced ultrasound examiner (‘subjective assessment’).
Ultrasound in Obstetrics & Gynecology | 2010
C. Van Holsbeke; B. Van Calster; S. Guerriero; L. Savelli; D. Paladini; Andrea Lissoni; A. Czekierdowski; D. Fischerova; J. Zhang; G Mestdagh; Antonia Carla Testa; Tom Bourne; Lil Valentin; D. Timmerman
To describe the ultrasound characteristics of endometriomas in pre‐ and postmenopausal patients and to develop rules that characterize endometriomas.
British Journal of Cancer | 2007
F. Amant; A De Knijf; B. Van Calster; Karin Leunen; P Neven; Patrick Berteloot; Ignace Vergote; S. Van Huffel; Philippe Moerman
The objective of this study is to assess the therapeutic importance of surgical castration, adjuvant hormonal treatment and lymphadenectomy in endometrial stromal sarcoma (ESS). A retrospective and multicentric search was performed. Clinicopathologic data were retrieved from cases that were confirmed to be ESS after central pathology review. The protocol was approved by the Ethical Committee. ESS was confirmed histopathologically in 34 women, but follow-up data were available in only 31 women. Surgical treatment (n=31) included hysterectomy with or without bilateral salpingo-oophorectomy (BSO) in 23 out of 31 (74%) and 8 out of 31 (26%) cases, respectively. Debulking surgery was performed in 6 out of 31 cases (19%). Stage distribution was as follows: 22 stage I, 4 stage III and 5 stage IV. Women with stage I disease recurred in 4 out of 22 (18%) cases. Among stage I women undergoing hormonal treatment with or without BSO, 3 out of 15 (20%) and 1 out of 7 (14%) relapsed, respectively. Among stages III–IV women receiving adjuvant hormonal treatment or not, 1 out of 5 (20%) and 3 out of 4 (75%) relapsed, respectively (differences=55.0%, 95% CI=−6.8–81.2%). Kaplan–Meier curves show comparable recurrence rates for stage I disease without adjuvant hormonal treatment when compared to stages III–IV disease treated with surgery and adjuvant hormonal treatment. Furthermore, women taking hormones at diagnosis have a better outcome when compared to women not taking hormonal treatment. Three out of 31 (9%) patients had a systematic lymphadenectomy whereas 3 out of 31 (9%) had a lymph node sampling. In one case, obvious nodal disease was encountered at presentation. Isolated retroperitoneal recurrence occurred in 1 out of 31 (3%) of all cases and in 1 out of 8 (13%) recurrences. This single woman later also developed lung and abdominal metastases. Leaving lymph nodes in situ does not appear to alter the clinical outcome of ESS. Although numbers are low, the retrospective data suggest that the need for surgical castration (BSO) in premenopausal women with early-stage disease should be discussed with the patient on an individual basis. The data support the current practice in some centres to administer adjuvant hormonal treatment.
Hormones and Behavior | 2008
B.R.H. Van den Bergh; B. Van Calster; S. Pinna Puissant; S. Van Huffel
The association between self-reported symptoms and diurnal cortisol profiles was studied in post-puberty adolescents (29 boys and 29 girls, M(age)=15.06 years). The adolescents completed the Childrens Depression Inventory, State Trait Anxiety Inventory, and an Aggressive behavior scale. The diurnal cortisol profile was derived from three saliva samples, collected at awakening, noon and evening on a week-end day. Univariate repeated measurement regressions revealed that depressed mood and trait anxiety were strongly and aggressive behavior was weakly related to the diurnal cortisol profile: greater emotional distress was associated with flatter diurnal cortisol profiles. Multivariate analysis, however, revealed that only trait anxiety made an independent contribution. Further analyses suggested that trait anxiety was related to elevated evening cortisol rather than to decreased awakening cortisol and that from a trait anxiety score of 38 onwards, high anxious adolescents show clearly higher evening cortisol than low anxious adolescents. These data suggest that anxiety disorder co-morbidity might explain some of the differences in HPA-axis function among depressed patients.
Ultrasound in Obstetrics & Gynecology | 2007
G. Condous; B. Van Calster; E. Kirk; Z. Haider; D. Timmerman; S. Van Huffel; Tom Bourne
We have previously published on the use of mathematical Model M1 to predict ectopic pregnancy in women with no signs of intra‐ or extrauterine pregnancy. The aim of this study was to improve on the performance of this model for the detection of developing ectopic pregnancies in women with pregnancies of unknown location (PULs). We therefore generated and evaluated a new logistic regression model from simple hormonal data and compared it with Model M1.
Ultrasound in Obstetrics & Gynecology | 2009
Lil Valentin; D. Jurkovic; B. Van Calster; Antonia Carla Testa; C. Van Holsbeke; Tom Bourne; Ignace Vergote; S. Van Huffel; Dirk Timmerman
To determine whether CA 125 measurement is superior to ultrasound imaging performed by an experienced examiner for discriminating between benign and malignant adnexal lesions, and to determine whether adding CA 125 to ultrasound examination improves diagnostic performance.
Ultrasound in Obstetrics & Gynecology | 2013
Jeroen Kaijser; Tom Bourne; Lil Valentin; A. Sayasneh; C. Van Holsbeke; Ignace Vergote; Antonia Carla Testa; D. Franchi; B. Van Calster; D. Timmerman
In order to ensure that ovarian cancer patients access appropriate treatment to improve the outcome of this disease, accurate characterization before any surgery on ovarian pathology is essential. The International Ovarian Tumor Analysis (IOTA) collaboration has standardized the approach to the ultrasound description of adnexal pathology. A prospectively collected large database enabled previously developed prediction models like the risk of malignancy index (RMI) to be tested and novel prediction models to be developed and externally validated in order to determine the optimal approach to characterize adnexal pathology preoperatively. The main IOTA prediction models (logistic regression model 1 (LR1) and logistic regression model 2 (LR2)) have both shown excellent diagnostic performance (area under the curve (AUC) values of 0.96 and 0.95, respectively) and outperform previous diagnostic algorithms. Their test performance almost matches subjective assessment by experienced examiners, which is accepted to be the best way to classify adnexal masses before surgery. A two‐step strategy using the IOTA simple rules supplemented with subjective assessment of ultrasound findings when the rules do not apply, also reached excellent diagnostic performance (sensitivity 90%, specificity 93%) and misclassified fewer malignancies than did the RMI. An evidence‐based approach to the preoperative characterization of ovarian and other adnexal masses should include the use of LR1, LR2 or IOTA simple rules and subjective assessment by an experienced examiner. Copyright
Ultrasound in Obstetrics & Gynecology | 2011
A. Pexsters; Jan Luts; D. Van Schoubroeck; C. Bottomley; B. Van Calster; S. Van Huffel; Y. Abdallah; Thomas D'Hooghe; C. Lees; D. Timmerman; Tom Bourne
To assess intra‐ and interobserver agreement of routinely performed measurements—crown–rump length (CRL) and mean gestational sac diameter (MSD)—for assessing the likelihood of miscarriage in the first trimester of pregnancy using transvaginal sonography.
British Journal of Obstetrics and Gynaecology | 2006
G Condous; E. Kirk; B. Van Calster; S. Van Huffel; D. Timmerman; Tom Bourne
Objective To assess the performance of the human chorionic gonadotrophin (hCG) ratio (hCG 48 hours/hCG 0 hour) to predict spontaneous resolution of pregnancies of unknown location (PUL).